AmerisourceBergen Corporation is a leading global healthcare solutions company that specializes in pharmaceutical distribution, specialty pharmaceuticals, and related services. The company was founded in 2001 and is headquartered in Chesterbrook, Pennsylvania.
One of the key strengths of AmerisourceBergen is its global distribution network. The company operates in over 50 countries worldwide, and has a network of distribution centers that allows it to efficiently and effectively deliver pharmaceutical products to customers. AmerisourceBergen's distribution services include drug distribution, clinical trial supply management, and specialty distribution services.
Another area where AmerisourceBergen excels is in its focus on specialty pharmaceuticals. The company has developed expertise in several therapeutic areas, including oncology, hematology, and immunology, and offers a range of specialized services to support these areas. This includes patient assistance programs, reimbursement support, and other services designed to help patients access the care they need.
AmerisourceBergen also has a strong commitment to innovation. The company invests heavily in research and development to develop new solutions and improve existing ones. AmerisourceBergen has a team of over 1,000 scientists and researchers who work to develop new drugs, devices, and other healthcare products.
In addition to its distribution and specialty pharmaceuticals businesses, AmerisourceBergen also offers a range of related services, including consulting services, data analytics, and technology solutions. The company's consulting services help customers optimize their supply chain operations and improve their business processes, while its data analytics and technology solutions help customers make better-informed decisions about their healthcare operations.
AmerisourceBergen has a strong track record of financial performance. The company has consistently generated strong earnings and revenue growth, and has a solid balance sheet with low leverage and ample liquidity. This has allowed AmerisourceBergen to continue its investment in research and development, as well as strategic acquisitions and partnerships.
In recent years, AmerisourceBergen has continued to expand its services and geographic reach through strategic acquisitions and partnerships. The company acquired H. D. Smith in 2018, which expanded its presence in the independent pharmacy market, and has partnerships with several leading pharmaceutical companies to develop new therapies and bring them to market.
AmerisourceBergen Corporation is a leading global healthcare solutions company that has built a reputation for its distribution and specialty pharmaceuticals businesses, commitment to innovation, and strong financial performance. With a global distribution network, a focus on specialty pharmaceuticals, and a range of related services, the company is well-positioned to continue its success in the years to come.